In Response to Arcidiacono et al.: "Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?".
Saskia A Cooke
,
Jan-Jakob Sonke
,
José S A Belderbos
,
Dirk de Ruysscher
More about this publication
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Volume
185
Pages
109690
Publication date
01-08-2023
Full text links
Publisher website (DOI)
10.1016/j.radonc.2023.109690
Europe PubMed Central
37164108
Pubmed
37164108